Selected Publications
Journal Articles
Daunt A, Perez-Guzman PN, Liew F, et al.Daunt A, Perez-Guzman PN, Liew F, Hauck K, Costelloe CE, Thursz MR, Cooke G, Nayagam S close, 2020, Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease, Journal of Infection, Vol:81, ISSN:0163-4453, Pages:666-668
Perez Guzman PN, Daunt A, Mukherjee S, et al.Perez Guzman PN, Daunt A, Mukherjee S, Crook P, Forlano R, Kont M, Lochen A, Vollmer M, Middleton P, Judge R, Harlow C, Soubieres A, Cooke G, White PJ, Hallett T, Aylin P, Ferguson N, Hauck K, Thursz M, Nayagam S close, 2020, Clinical characteristics and predictors of outcomes of hospitalized patients with COVID-19 in a multi-ethnic London NHS Trust: a retrospective cohort study, Clinical Infectious Diseases, ISSN:1058-4838
Walker PGT, Whittaker C, Watson OJ, et al.Walker PGT, Whittaker C, Watson OJ, Baguelin M, Winskill P, Hamlet A, Djafaara BA, Cucunubá Z, Olivera Mesa D, Green W, Thompson H, Nayagam S, Ainslie KEC, Bhatia S, Bhatt S, Boonyasiri A, Boyd O, Brazeau NF, Cattarino L, Cuomo-Dannenburg G, Dighe A, Donnelly CA, Dorigatti I, van Elsland SL, FitzJohn R, Fu H, Gaythorpe KAM, Geidelberg L, Grassly N, Haw D, Hayes S, Hinsley W, Imai N, Jorgensen D, Knock E, Laydon D, Mishra S, Nedjati-Gilani G, Okell LC, Unwin HJ, Verity R, Vollmer M, Walters CE, Wang H, Wang Y, Xi X, Lalloo DG, Ferguson NM, Ghani AC close, 2020, The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries, Science, Vol:369, ISSN:0036-8075, Pages:413-422
Nayagam AS, Chan P, Zhao K, et al.Nayagam AS, Chan P, Zhao K, Sicuri E, Wang X, Jia J, Wei L, Walsh N, Rodewald LE, Zhang G, Ailing W, Zhang L, Chang J, Hou C, Qiu Y, Sui B, Xiao Y, Zhuang H, Thursz M, Scano F, Low-Beer D, Schwartländer B, Wang Y, Hallett TB close, 2020, Investment case for a comprehensive package of interventions against Hepatitis B in China; applied modelling to help national strategy planning, Clinical Infectious Diseases, ISSN:1058-4838
Nayagam S, Shimakawa Y, Lemoine M, 2020, Mother-to-child transmission of hepatitis B: What more needs to be done to eliminate it around the world?, Journal of Viral Hepatitis, Vol:27, ISSN:1345-2533, Pages:342-349
Heffernan A, Cooke G, Nayagam S, et al.Heffernan A, Cooke G, Nayagam S, Hallett TB, Thursz M close, 2019, Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model, The Lancet, Vol:393, ISSN:0140-6736, Pages:1319-1329
Cooke GS, Andrieux-Meyer I, Applegate TL, et al.Cooke GS, Andrieux-Meyer I, Applegate TL, Atun R, Burry JR, Cheinquer H, Dusheiko G, Feld JJ, Gore C, Griswold MG, Hamid S, Hellard ME, Hou JL, Howell J, Jia J, Kravchenko N, Lazarus JV, Lemoine M, Lesi OA, Maistat L, McMahon BJ, Razavi H, Roberts TR, Simmons B, Sonderup MW, Spearman CW, Taylor BE, Thomas DL, Waked I, Ward JW, Wiktor SZ, Abdo A, Aggarwal R, Aghemo A, Al-Judaibi B, Al Mahtab M, Altaf A, Ameen Z, Asselah T, Baatarkkhuu O, Barber E, Barnes E, Boulet P, Burrows L, Butsashvili M, Chan E, Chow C, Cowie B, Cunningham C, de Araujo A, Diap G, Dore G, Doyle J, Elsayed M, Fajardo E, Gane E, Getehun A, Goldberg D, Got T, Hickman M, Hill A, Hutchinson S, Jones C, Kamili S, Khan A, Lee A, Lee TY, Malani J, Morris TM, Nayagam S, Njouom R, Ocama P, Pedrana A, Peeling R, Reddy A, Roberts T, Sacks J, Sarin S, Shimakawa Y, Silva M, Skala P, Taylor-Robinson S, Thompson A, Thursz M, Tonganibeia A, Wallace J, Ward J, Wolff F, Vickerman P, Yau J close, 2019, Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission, The Lancet Gastroenterology and Hepatology, Vol:4, ISSN:2468-1253, Pages:135-184
Yusuke S, Njie R, Ndow G, et al.Yusuke S, Njie R, Ndow G, Vray M, Mbaye PS, Bonnard P, Sombie R, Nana J, Leroy V, Bottero J, Ingiliz P, Post G, Sanneh B, Baldeh I, Suso P, Ceesay A, Jeng A, Njai HF, Nayagam S, D'Alessandro U, Chemin I, Mendy M, Thursz M, Lemoine M close, 2018, Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa, Journal of Hepatology, Vol:69, ISSN:0168-8278, Pages:776-784
Hecht R, Hiebert L, Spearman WC, et al.Hecht R, Hiebert L, Spearman WC, Sonderup MW, Guthrie T, Hallett TB, Nayagam S, Razavi H, Soe-Lin S, Vilakazi-Nhlapo K, Pillay Y, Resch S close, 2018, The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up, Health Policy and Planning, Vol:33, ISSN:1460-2237, Pages:528-538
Nayagam S, Thursz M, Sicuri E, et al.Nayagam S, Thursz M, Sicuri E, Conteh L, Wiktor S, Low-Beer D, Hallett TB close, 2016, Requirements for global elimination of hepatitis B: a modelling study., Lancet Infectious Diseases, Vol:16, ISSN:1473-3099, Pages:1399-1408
Lemoine MN, Shimakawa Y, Njie R, et al.Lemoine MN, Shimakawa Y, Njie R, Taal M, Ndow G, Chemin I, Ghosh S, Njai HF, Jeng A, Sow A, Toure-Kane C, Mboup S, Suso P, Tamba T, Jatta A, Sarr L, Kambi A, Stanger W, Nayagam S, Howell J, Mpabanzi L, Nyan O, Corrah T, Whittle H, Taylor-Robinson SD, D’Alessandro U, Mendy M, Thursz MR close, 2016, Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study, Lancet Global Health, Vol:4, ISSN:2214-109X, Pages:e559-e567
Nayagam S, Conteh L, Sicuri E, et al.Nayagam S, Conteh L, Sicuri E, Shimakawa Y, Tamba S, Suso P, Njie R, Njai H, Lemoine M, Hallett TB, Thursz M close, 2016, Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis, Lancet Global Health, Vol:4, ISSN:2214-109X, Pages:e568-e578
More Publications
